Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...
HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...
2 VCSG Government Medical Sciences and Research Institute, Srinagar (Garhwal), Uttarakhand, India The clinical presentation of an adolescent man with left lung hypoplasia is described in detail ...
Modern neonatal care offers significant hope for newborns with severe lung issues, debunking old myths of inevitable fatality. Experts emphasize that advanced treatments, including ventilation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback